0.004
Aequus Pharmaceuticals Inc Stock (AQSZF) Forecast
The Aequus Pharmaceuticals Inc (AQSZF) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $0.1622, representing a +3,956% increase from the current price of $0.004. The highest analyst price target is $0.1755, and the lowest is $0.1489.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month AQSZF Price Target
Average 0.1638
(+3,996% Upside)
Long-term AQSZF price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Aequus Pharmaceuticals Inc financial reports and earnings history, Aequus Pharmaceuticals Inc (AQSZF) stock could reach $0.5147 by 2030, $0.8734 by 2040 and $1.8305 by 2050. See the projected annual prices until 2050 of the Aequus Pharmaceuticals Inc stock below:
- Aequus Pharmaceuticals Inc (AQSZF) is expected to reach an average price of $0.6416 in 2035, with a high prediction of $0.761 and a low estimate of $0.6422. This indicates an $15,941% rise from the last recorded price of $0.004.
- Aequus Pharmaceuticals Inc (AQSZF) stock is projected to chart a bullish course in 2040, with an average price target of $0.7517, representing an $18,693% surge from its current level. The forecast ranges from a conservative $0.7517 to a sky-high $0.8734.
- Our analysts predict Aequus Pharmaceuticals Inc (AQSZF) to jump 40,469% by 2045, soaring from $0.815 to an average price of $1.6228, potentially reaching $1.6496. While $0.815 is the low estimate, the potential upside is significant.
- Aequus Pharmaceuticals Inc (AQSZF) stock is expected to climb by 2050, reaching an average of $1.6205, a $40,412% jump from its current level. However, a wide range of estimates exists, with high and low targets of $1.8305 and $1.6217, respectively, highlighting the market's uncertainty.
Aequus Pharmaceuticals Inc Stock (AQSZF) Year by Year Forecast
Aequus Pharmaceuticals Inc Stock (AQSZF) Price Forecast for 2025
Aequus Pharmaceuticals Inc Stock (AQSZF) is expected to reach an average price of $0.1293 in 2025, with a high prediction of $0.1981 and a low estimate of $0.0604. This indicates an +3,132% rise from the last recorded price of $0.004.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
June, 2025 | $0.1474 | $0.1489 | $0.1755 | +3,584% |
July, 2025 | $0.1114 | $0.112 | $0.1332 | +2,684% |
August, 2025 | $0.0956 | $0.0956 | $0.1064 | +2,291% |
September, 2025 | $0.1905 | $0.0843 | $0.1754 | +4,662% |
October, 2025 | $0.1501 | $0.1501 | $0.1981 | +3,652% |
November, 2025 | $0.1232 | $0.1232 | $0.137 | +2,980% |
December, 2025 | $0.0976 | $0.0976 | $0.1125 | +2,339% |
Aequus Pharmaceuticals Inc Stock (AQSZF) Price Forecast for 2026
The predicted value for Aequus Pharmaceuticals Inc (AQSZF) in 2026 is set at an average of $0.1922. Estimates vary from a peak of $0.2886 to a trough of $0.0959, indicating an +4,706% surge from the present price of $0.004.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2026 | $0.1926 | $0.0959 | $0.2207 | +4,715% |
February, 2026 | $0.1635 | $0.1647 | $0.1894 | +3,987% |
March, 2026 | $0.1269 | $0.1359 | $0.1548 | +3,072% |
April, 2026 | $0.1173 | $0.1075 | $0.1272 | +2,834% |
May, 2026 | $0.2105 | $0.2144 | $0.2434 | +5,162% |
June, 2026 | $0.1727 | $0.1832 | $0.194 | +4,218% |
July, 2026 | $0.1375 | $0.1375 | $0.1583 | +3,338% |
August, 2026 | $0.2607 | $0.1191 | $0.2456 | +6,418% |
September, 2026 | $0.2085 | $0.2085 | $0.266 | +5,112% |
October, 2026 | $0.1722 | $0.1722 | $0.193 | +4,204% |
November, 2026 | $0.1392 | $0.1507 | $0.1579 | +3,381% |
December, 2026 | $0.2581 | $0.1307 | $0.2886 | +6,352% |
Aequus Pharmaceuticals Inc Stock (AQSZF) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Aequus Pharmaceuticals Inc (AQSZF) is $0.2494, with a high forecast of $0.3564 and a low forecast of $0.1423. This indicates an +6,134% increase from the last price of $0.004.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2027 | $0.2195 | $0.2207 | $0.2526 | +5,388% |
February, 2027 | $0.1735 | $0.1825 | $0.2085 | +4,236% |
March, 2027 | $0.1569 | $0.1423 | $0.1714 | +3,822% |
April, 2027 | $0.2736 | $0.2794 | $0.3112 | +6,740% |
May, 2027 | $0.2264 | $0.2369 | $0.2547 | +5,560% |
June, 2027 | $0.1794 | $0.1794 | $0.2096 | +4,385% |
July, 2027 | $0.3309 | $0.1539 | $0.3158 | +8,172% |
August, 2027 | $0.275 | $0.282 | $0.3338 | +6,774% |
September, 2027 | $0.2211 | $0.2211 | $0.2549 | +5,428% |
October, 2027 | $0.1788 | $0.1903 | $0.2045 | +4,369% |
November, 2027 | $0.3564 | $0.1655 | $0.3564 | +8,811% |
December, 2027 | $0.2756 | $0.2768 | $0.3236 | +6,789% |
Aequus Pharmaceuticals Inc Stock (AQSZF) Price Forecast for 2028
In 2028, Aequus Pharmaceuticals Inc (AQSZF) is projected to reach an average price of $0.3007, with a high projection of $0.4243 and a low estimate of $0.1771. This indicates an +7,417% rise from the last price of $0.004.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2028 | $0.2201 | $0.2291 | $0.2622 | +5,401% |
February, 2028 | $0.1843 | $0.1843 | $0.2157 | +4,506% |
March, 2028 | $0.3367 | $0.1771 | $0.379 | +8,318% |
April, 2028 | $0.2801 | $0.2906 | $0.3155 | +6,902% |
May, 2028 | $0.2213 | $0.2213 | $0.2609 | +5,432% |
June, 2028 | $0.4011 | $0.1887 | $0.386 | +9,927% |
July, 2028 | $0.3357 | $0.3428 | $0.4017 | +8,293% |
August, 2028 | $0.2701 | $0.2701 | $0.3133 | +6,652% |
September, 2028 | $0.2183 | $0.2298 | $0.2511 | +5,357% |
October, 2028 | $0.4243 | $0.2003 | $0.4243 | +10,507% |
November, 2028 | $0.3316 | $0.3328 | $0.389 | +8,190% |
December, 2028 | $0.2667 | $0.2757 | $0.3159 | +6,566% |
Aequus Pharmaceuticals Inc Stock (AQSZF) Price Forecast for 2029
The 2029 price forecast for Aequus Pharmaceuticals Inc Stock (AQSZF) is $0.352 on average, with a high prediction of $0.4921 and a low estimate of $0.2119. This represents an +8,700% increase from the previous price of $0.004.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2029 | $0.2359 | $0.2119 | $0.2599 | +5,798% |
February, 2029 | $0.3998 | $0.4056 | $0.4469 | +9,896% |
March, 2029 | $0.3338 | $0.3443 | $0.3762 | +8,244% |
April, 2029 | $0.2804 | $0.2804 | $0.3122 | +6,909% |
May, 2029 | $0.4713 | $0.2235 | $0.4562 | +11,682% |
June, 2029 | $0.3965 | $0.4036 | $0.4695 | +9,812% |
July, 2029 | $0.3337 | $0.3343 | $0.3717 | +8,243% |
August, 2029 | $0.2578 | $0.2693 | $0.3185 | +6,345% |
September, 2029 | $0.4921 | $0.2351 | $0.4921 | +12,203% |
October, 2029 | $0.3876 | $0.3888 | $0.4545 | +9,591% |
November, 2029 | $0.3133 | $0.3223 | $0.3695 | +7,731% |
December, 2029 | $0.2586 | $0.2586 | $0.3042 | +6,364% |
Aequus Pharmaceuticals Inc Stock (AQSZF) Price Forecast for 2030
Aequus Pharmaceuticals Inc Stock (AQSZF) is expected to reach an average price of $0.4146 in 2030, with a high forecast of $0.5826 and a low forecast of $0.2467. This signifies an +10,265% surge from the last price of $0.004.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2030 | $0.463 | $0.2467 | $0.5147 | +11,474% |
February, 2030 | $0.3874 | $0.3979 | $0.437 | +9,586% |
March, 2030 | $0.3246 | $0.3246 | $0.3635 | +8,015% |
April, 2030 | $0.2817 | $0.2583 | $0.305 | +6,941% |
May, 2030 | $0.4572 | $0.4643 | $0.5373 | +11,331% |
June, 2030 | $0.3851 | $0.3857 | $0.4301 | +9,526% |
July, 2030 | $0.2973 | $0.3088 | $0.3675 | +7,333% |
August, 2030 | $0.5599 | $0.2699 | $0.5599 | +13,899% |
September, 2030 | $0.4615 | $0.4615 | $0.52 | +11,438% |
October, 2030 | $0.3599 | $0.3689 | $0.4359 | +8,896% |
November, 2030 | $0.2957 | $0.2957 | $0.3484 | +7,293% |
December, 2030 | $0.5418 | $0.2815 | $0.5826 | +13,445% |
Cap:
|
Volume (24h):